Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  He, Fang ^a   Fu, Ying ^a   Chen, Qiong ^a   Ruan, Zhi ^a   Hua, Xiaoting ^a   Zhou, Hua ^a   Yu, Yunsong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TIGECYCLINE; 1-(1-NAPHTHYLMETHYL)PIPERAZINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE KPC-1; MINOCYCLINE; MULTIDRUG RESISTANCE PROTEIN; PIPERAZINE DERIVATIVE;

ACRB GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CHINA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; KLEBSIELLA PNEUMONIAE; MARA GENE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; OQXB GENE; RAMA GENE; RARA GENE; REAL TIME POLYMERASE CHAIN REACTION; SOXS GENE; ANALOGS AND DERIVATIVES; BACTERIUM TRANSFORMATION; DRUG EFFECTS; GENE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; REGULATOR GENE;

KLEBSIELLA PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, MDR; GENES, REGULATOR; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PIPERAZINES; TRANSFORMATION, BACTERIAL;

EID: 84928920459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119064     Document Type: Article

References (27)

1. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66:307-312. doi: 10.1093/jac/dkq431 PMID: 21131324
2. Pankey GA. Tigecycline. J Antimicrob Chemother. 2005;56:470-480. PMID: 16040625
3. Jenner L, Starosta AL, Terry DS, Mikolajka A, Filonava L, Yusupov M, et al. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc Natl Acad Sci USA. 2013;110:3812-3816. doi: 10.1073/pnas.1216691110 PMID: 23431179
4. Ruzin A, Visalli MA, Keeney D, Bradford PA. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2005;49:1017-1022. PMID: 15728897
5. Ruzin A, Immermann FW, Bradford PA. Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2008;52:3430-3432. doi: 10.1128/AAC.00591-08 PMID: 18625776
6. Di Persio JR, Dowzicky MJ. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. Int J Antimicrob Agents. 2007;29:518-527. PMID: 17376657
7. Vazquez MF, Romero ED, Garcia MI, Rodriguez JA, Bellido JL. Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamases. Int J Antimicrob Agents. 2008;32:541-543. doi: 10.1016/j.ijantimicag.2008.06.024 PMID: 18789848
8. Roy S, Datta S, Viswanathan R, Singh AK, Basu S. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J Antimicrob Chemother. 2013;68:1036-1042. doi: 10.1093/jac/dks535 PMID: 23335112
9. De Majumdar S, Veleba M, Finn S, Fanning S, Schneiders T. Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57:1603-1609. doi: 10.1128/AAC.01998-12 PMID: 23318802
10. Schneiders T, Amyes SG, Levy SB. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother. 2003;47:2831-2837. PMID: 12936981
11. Bratu S, Landman D, George A, Salvani J, Quale J. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J Antimicrob Chemother. 2009;64:278-283. doi: 10.1093/jac/dkp186 PMID: 19457933
12. Veleba M, Schneiders T. Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2012;56:4466-4467. doi: 10.1128/AAC.06224-11 PMID: 22644034
13. Ricci V, Blair JM, Piddock LJ. RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease. J Antimicrob Chemother. 2014;69:643-650. doi: 10.1093/jac/dkt432 PMID: 24169580
14. Bialek-Davenet S, Marcon E, Leflon-Guibout V, Lavigne JP, Bert F, Moreau R, et al. In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55:2795-2802. doi: 10.1128/AAC.00156-11 PMID: 21464248
15. Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher M. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob Agents Chemother. 2010;54:2720-2723. doi: 10.1128/AAC.00085-10 PMID: 20350947
16. Keeney D, Ruzin A, McAleese F, Murphy E, Bradford PA. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother. 2008;61:46-53. PMID: 17967850
17. Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, et al. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother. 2009;53:4333-4338. doi: 10.1128/AAC.00260-09 PMID: 19620332
18. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1. 2013.
19. Schumacher A, Steinke P, Bohnert JA, Akova M, Jonas D, Kern WV. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother. 2006;57:344-348. PMID: 16354746
20. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362:1804-1813. doi: 10.1056/NEJMra0904124 PMID: 20463340
21. Rodriguez-Avial C, Rodriguez-Avial I, Merino P, Picazo JJ. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect. 2012;18:61-66. doi: 10.1111/j.1469-0691.2011.03482.x PMID: 21722259
22. Tsai HY, Liao CH, Cheng A, Liu CY, Huang YT, Sheng WH, et al. Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenemresistant Escherichia coli. J Infect. 2012;65:584-586. doi: 10.1016/j.jinf.2012.09.007 PMID: 23000236
23. Nigo M, Cevallos CS, Woods K, Flores VM, Francis G, Perlman DC, et al. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57:5743-5746. doi: 10.1128/AAC.00827-13 PMID: 23979745
24. Van Duin D, Cober E, Richter SS, Perez F, Cline M, Kaye KS, et al. Tigecycline Therapy for Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Bacteriuria Leads to Tigecycline Resistance. Clin Microbiol Infect. 2014.
25. Kern WV, Steinke P, Schumacher A, Schuster S, Von Baum H, Bohnert JA. Effect of 1-(1-naphthylmethyl) - piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother. 2006;57:339-343. PMID: 16354747
26. Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb Drug Resist. 2007;13:1-6. PMID: 17536927
27. Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother. 2009;63:659-667. doi: 10.1093/jac/dkp029 PMID: 19233898